skip to Main Content
Trustee Joseph Irwin Looks Back At 30 Years Of Changes In EU Legislation In Drug Development For Rare Diseases In His Latest Paper

Trustee Joseph Irwin looks back at 30 years of changes in EU legislation in drug development for rare diseases in his latest paper

TreatSMA trustee Joseph Irwin looks back at 30 years of changes in EU legislation in drug development for rare diseases in his latest paper.

In the latest volume of Regulatory Rapporteur, TreatSMA trustee Joseph Irwin has publish a paper titled  ‘A look back at 30 years of changes in EU legislation in drug development for rare diseases’. In this paper Joseph reflects on some milestones of the evolving EU framework for the development and evaluation of medicines for rare diseases.

TreatSMA are incredibly thankful for, and proud of, the research and contributions Joseph has made to research for rare diseases in the last 30 years. For his full paper, please see the link below.

A look back at 30 years of changes in EU legislation in drug development for rare diseases

Back To Top